Product Details
Insulin Resistance

Insulin Resistance
From WileyBlackwell

List Price: £190.00
Price: £161.50 & eligible for FREE Super Saver Delivery on orders over £5. Details

Availability: Usually dispatched within 1 to 3 weeks
Dispatched from and sold by Amazon.co.uk

23 new or used available from £29.25

Product Description

Recognized authorities in their respective areas provide contemporary information on insulin resistance. Organized into 12 chapters covering a broad range of subjects pertaining to insulin action, mechanisms of insulin resistance and clinical consequences, this book integrates and unites recent advances which have occurred in several disparate fields. The role of defects in the glucose transport system and future approaches to specific treatment of insulin resistance are among the topics discussed.


Product Details

  • Amazon Sales Rank: #3747017 in Books
  • Published on: 1993-08-16
  • Original language: English
  • Number of items: 1
  • Binding: Hardcover
  • 440 pages

Editorial Reviews

From the Back Cover
The past two decades have seen explosive gains in our understanding of the physiology and basic mechanisms of insulin action and the critical importance of insulin resistance in the pathogenesis of clinical disorders such as non–insulin dependent diabetes mellitus, essential hypertension and atherosclerotic cardiovascular disease.
Insulin Resistance offers the first comprehensive review of the field, with integrated chapters providing up to date coverage of the essential components of basic and clinical research that have contributed to current understanding of the topic. There are chapters on basic mechanisms of insulin action, in depth discussions of insulin resistance syndromes from epidemiological, clinical and biochemical viewpoints and a discussion of therapeutic approaches to insulin resistance.
Insulin Resistance will be an invaluable resource for clinicians and scientists with an interest in the mechanisms of insulin action, the clinical sequelae of hyperinsulinemia and future therapies of insulin resistance.

About the Author
David E. Moller MD of the Harvard Medical School, Beth Israel Hospital, Boston, Massachusetts, USA